[1] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2] BERGER H,MARQUES M S,ZIETLOW R,et al.Gastric cancer pathogenesis[J].Helicobacter,2016,21(Suppl 1):34-38.
[3] 左婷婷,郑荣寿,曾红梅,等.中国胃癌流行病学现状[J].中国肿瘤临床,2017,44(1):52-58.
[4] LI P,LIU H,WANG Z Y,et al.MicroRNAs in laryngeal cancer:implications for diagnosis,prognosis and therapy[J].Am J Transl Res,2016,8(5):1935-1944.
[5] ZHAO Z J,WANG L,SONG W,et al.Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer[J].World J Surg Oncol,2015,13:101-107.
[6] GAN Q,LIU Q,HU X,et al.Collagen type Ⅰ alpha 2(COL1A2) polymorphism contributes to intracranial aneurysm susceptibility:a meta-analysis[J].Med Sci Monit,2017,23:3240-3246.
[7] MIYAKE M,HORI S,MORIZAWA Y,et al.Collagen type Ⅳ alpha 1(COL4A1) and collagen type ⅩⅢ alpha 1(COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder[J].Oncotarget,2017,8(22):36099-36114.
[8] CHEN L,JANETOPOULOS C,HUANG Y E,et al.Two phases of actin polymerization display different dependencies on PI (3,4,5) P3 accumulation and have unique roles during chemotaxis[J].Mol Biol Cell,2003,14(12):5028-5037.
[9] CHO J Y,LIM J Y,CHEONG J H,et al.Gene expression signature-based prognostic risk score in gastric cancer[J].Clin Cancer Res,2011,17(7):1850-1857.
[10] CUI J,CHEN Y,CHOU W C,et al.An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer[J].Nucleic Acids Res,2011,39(4):1197-1207.
[11] WANG X,ZHAO J,YANG L,et al.Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer[J].Med Oncol,2010,27(2):484-490.
[12] D'ERRICO G,VITIELLO G,D'URSI A M,et al.Interaction of short modified peptides deriving from glycoprotein gp36 of feline immunodeficiency virus with phospholipid membranes[J].Eur Biophys J,2009,38(7):873-882.
[13] SZASZ A M,LANCZKY A,NAGY A,et al.Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients[J].Oncotarget,2016,7(31):49322-49333.
[14] BORNSCHEIN J,SCHLOSSER S.Pathogenesis and prevention of gastric cancer[J].Der Gastroenterologe,2017,12(5):365-375.
[15] AKHTER M Z,LUTHRA K,RAJESWARI M R.Molecular aspects on adriamycin interaction with hmga1 regulatory region and its inhibitory effect on HMGA1 expression in human cervical cancer[J].J Biomol Struct Dyn,2016,34(4):877-891.
[16] PARK A C,PHAN N,MASSOUDI D,et al.Deficits in Col5a2 expression result in novel skin and adipose abnormalities and predisposition to aortic aneurysms and dissections[J].Am J Pathol,2017,187(10):2300-2311.
[17] PARK A C,PHILLIPS C L,PFEIFFER F M,et al.Homozygosity and heterozygosity for null Col5a2 alleles produce embryonic lethality and a novel classic Ehlers-Danlos syndrome-related phenotype[J].Am J Pathol,2015,185(7):2000-2011.
[18] ZENG X T,LIU X P,LIU T Z,et al.The clinical significance of COL5A2 in patients with bladder cancer:a retrospective analysis of bladder cancer gene expression data[J].Medicine (Baltimore),2018,97(10):e0091.
[19] JANUCHOWSKI R,SWIERCZEWSKA M,STERZYNSKA K,et al.Increased expression of several collagen genes is associated with drug resistance in ovarian cancer cell lines[J].J Cancer,2016,7(10):1295-1310.
[20] CHEN H C,TSENG Y K,SHU C W,et al.Differential clinical significance of COL5A1 and COL5A2 in tongue squamous cell carcinoma[J].J Oral Pathol Med,2019,48(6):468-476.
[21] VISHNOI A,RANI S.MiRNA biogenesis and regulation of diseases:an overview[J].Methods Mol Biol,2017,1509:1-1510.
[22] YANG Y,DODBELE S,PARK T,et al.MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway[J].J Neurooncol,2019,145(1):23-34.
[23] 朱海东,胡东坡.MicroRNA-34a-5p在肝纤维化中的表达及作用[J].东南大学学报(医学版),2019,38(5):859-865.
[24] 詹莹,安红伟.miRNA与血管性痴呆的研究进展[J].东南大学学报(医学版),2019,38(2):376-379.
[25] RUPAIMOOLE R,SLACK F J.MicroRNA therapeutics:towards a new era for the management of cancer and other diseases[J].Nat Rev Drug Discov,2017,16(3):203-222.
[26] LI C H,CHEN W,HU J Q,et al.miRNA-29a targets COL3A1 to regulate the level of type Ⅲ collagen in pig[J].Gene,2016,592(1):140-147. |